← Today’s ReceiptsSource pending
Public-record receiptD-TXSource pending
Christian Menefee disclosed SELL $BRK.B
Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.
Trade range
$15K – $50K
Filed
2026-06-02
Trade date
2026-02-10
Disclosure lag
112 days after trade
Why this receipt matters
A quick read before you share it.
These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.
1The disclosure is tracked with source status pending, so treat it as a record to verify rather than a finished source trail.
2The filing appeared 112 days after the trade date, beyond the standard 45-day STOCK Act window.
3The disclosed range is $15K – $50K, which is the public reporting band rather than an exact profit or loss figure.
417 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for Christian Menefee, but PoliWealth treats it as context - not proof of intent or wrongdoing.
6Related public-record context includes 5 lobbying filings.
Source
source pending
Source: indexed congressional disclosure; official source link pending · filed 2026-06-02 · disclosed 112d after transaction
Market context
Berkshire Hathaway Inc. Class B
Sector: Financials
Factual flags
- Filed after the standard 45-day STOCK Act window.
- 5 lobbying filings linked to this ticker.
- 17 nearby same-ticker disclosures in the surrounding 30-day window.
- Filed 112 days after the reported transaction date (standard disclosure window: 45 days).
- BRK.B transaction date was 21d after a public lobbying filing by BERKSHIRE HATHAWAY ENERGY ($210,000); this is timing context, not a finding of intent.
Member trail
Christian Menefee
U.S. House · TX-18
House Committee on ScienceSpaceand TechnologyHouse Committee on Oversight and Government Reform
Ticker trail
$BRK.B
Berkshire Hathaway Inc. Class B
Follow this tickerAlert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.